Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 2/2000

01-02-2000

Serum tocopherols, selenium and lung cancer risk among tin miners in China

Authors: Duminda Ratnasinghe, Joseph A. Tangrea, Michele R. Forman, Terry Hartman, Elaine W. Gunter, You-Lin Qiao, Shu-Xiang Yao, Michael J. Barett, Carol A. Giffen, Yener Erozan, Melvyn S. Tockman, Philip R. Taylor

Published in: Cancer Causes & Control | Issue 2/2000

Login to get access
Metadata
Title
Serum tocopherols, selenium and lung cancer risk among tin miners in China
Authors
Duminda Ratnasinghe
Joseph A. Tangrea
Michele R. Forman
Terry Hartman
Elaine W. Gunter
You-Lin Qiao
Shu-Xiang Yao
Michael J. Barett
Carol A. Giffen
Yener Erozan
Melvyn S. Tockman
Philip R. Taylor
Publication date
01-02-2000
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 2/2000
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1008977320811

Other articles of this Issue 2/2000

Cancer Causes & Control 2/2000 Go to the issue

OriginalPaper

Vegetable and fruit consumption and lung cancer risk in the Netherlands Cohort Study on Diet and Cancer

OriginalPaper

Parental occupational exposure to magnetic fields and childhood cancer (Sweden)

OriginalPaper

Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden)

Legacy

A research agenda for tobacco control

OriginalPaper

Deprived areas and attendance to screening of cervix uteri cancer in a French region

OriginalPaper

A pooled analysis of thyroid cancer studies. V. Anthropometric factors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits